Back to dashboard
CommercialAdministrativeLow impact

Albendazole

Blue Cross & Blue Shield of Mississippi·MS · Infectious Disease, Neurology, Gastroenterology·Medical Policy
Effective date
Sep 9, 2025
We identified it
Jun 20, 2026
Days to comply
—

Summary

BCBSMS updated their Albendazole policy with minor changes to the description and policy sections. The core coverage remains the same: 6 tablets per 180 days with benefit appeals required for higher quantities based on specific diagnostic criteria.

Action Required

Action needed
No immediate action required. This is a minor policy update that does not change coverage criteria, dosing requirements, or billing procedures. Continue following existing Albendazole prior authorization processes for quantities exceeding 6 tablets per 180 days.

Related policy hubs